The US Food and Drug Administration provides drug firms with a draft guidance on quality for eye drops and other topical ophthalmic products following a jump the past two years in contamination problems.
Need for the guidance was shown not only in recalls over the past year of OTC eye drops due to...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?